Literature DB >> 2918535

Teratogenicity of ergotamine.

A Czeizel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2918535      PMCID： PMC1015547          DOI： 10.1136/jmg.26.1.69-a

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  2 in total

1.  Aetiological monitor of congenital abnormalities: a case-control surveillance system.

Authors:  A Czeizel; A Pázsy; J Pusztai; M Nagy
Journal:  Acta Paediatr Hung       Date:  1983

2.  Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine.

Authors:  H E Hughes; D A Goldstein
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318
  2 in total
  4 in total

1.  Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study.

Authors:  Alissa R Van Zutphen; Martha M Werler; Marilyn M Browne; Paul A Romitti; Erin M Bell; Louise-Anne McNutt; Charlotte M Druschel; Allen A Mitchell
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

Review 2.  Migraine during pregnancy: is it more than a headache?

Authors:  Stephen A Contag; Heather L Mertz; Cheryl D Bushnell
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 42.937

3.  Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth.

Authors:  Ferenc Bánhidy; Nándor Acs; Erzsébet Puhó; Andrew E Czeizel
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

4.  Headache in pregnancy: a nuisance or a new sense?

Authors:  Archana Dixit; Manish Bhardwaj; Bhavna Sharma
Journal:  Obstet Gynecol Int       Date:  2012-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.